Increased rate of factor V Leiden mutation in patients with cerebral venous thrombosis.
- 1 March 1998
- journal article
- research article
- Published by Springer Nature in Zeitschrift für Neurologie
- Vol. 245 (3) , 149-152
- https://doi.org/10.1007/s004150050195
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Coagulation Studies, Factor V Leiden, and Anticardiolipin Antibodies in 40 Cases of Cerebral Venous ThrombosisStroke, 1996
- Factor V Leiden Mutation in Cerebral Venous ThrombosisStroke, 1996
- Validated Questionnaire for the Identification of Previous Personal or Familial Venous ThromboembolismAmerican Journal of Epidemiology, 1996
- Hyperhomocysteinemia as a Risk Factor for Deep-Vein ThrombosisNew England Journal of Medicine, 1996
- Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy MenNew England Journal of Medicine, 1995
- Cerebral venous and sinus thrombosis – an updateEuropean Journal of Neurology, 1994
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Resistance to Activated Protein C as a Basis for Venous ThrombosisNew England Journal of Medicine, 1994
- Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia StudyThe Lancet, 1993
- LABORATORY IDENTIFICATION OF THE LUPUS ANTICOAGULANTBritish Journal of Haematology, 1989